Who We Are
Biosynth is an innovative life sciences reagents, custom synthesis and manufacturing services company. We are by scientists, for scientists, securing supply chains with consistent quality, across the globe. We manufacture and source a vast range of chemical and biochemical products, and take pride in delivering products that others cannot. We are experts in complex chemistry, peptides and key biological raw materials. We provide a full range of products and services to support life sciences research and development, with more than a million products in our research catalog and hundreds of complex manufacturing service projects. Our complex chemistry specialties include enzyme substrates, carbohydrate and nucleoside chemistry, with manufacturing services from the first idea to the finished product, from route scouting to GMP or ton scale production. For peptides, we also have a full end-to-end offering, from lead discovery and optimization, library production, through to GMP NCE or Neoantigen projects.
Across biologics we have a synergistic offering, with an extensive range of custom bioprocessing enzyme projects for production of key products. We are also able to offer custom antibody projects, and epitope mapping. Through the Biosynth group we also offer development of antibodies, antigens and supply of plasma for in vitro diagnostics.
The trusted supplier, manufacturer and partner for the pharmaceutical,life sciences and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network. Our main chemical research and
manufacturing laboratories are in Switzerland, the United Kingdom, Slovakia and China, with peptide production in the USA and the Netherlands. Enzyme projects are based in Austria and biological IVD reagents in Ireland. Our R&D resources and production facilities are modern and versatile, allowing us to produce chemicals on the milligram to ton scale, and at ISO 9001 and GMP,
with peptides at mg to multikilogram scale.
History
Biosynth was founded in 1966 by Hans Spitz, and has grown to a global products and services business. Biosynth merged with Carbosynth in 2019 to form Biosynth Carbosynth, creating a world leader in carbohydrates, nucleosides and enzyme substrates. In 2022 Biosynth Group acquired both vivitide and Pepscan, which strengthened the offering in peptide manufacturing services and catalog products. Also in 2022 Biosynth Group acquired Aalto Bio Reagents, expanding the range of biological products and key raw materials for clinical diagnostics including antigens and antibodies, as well as EUCODIS Bioscience, experts in Enzyme development. Following these acquisitons, the company returned to the Biosynth brand. Biosynth is owned by KKR, Ampersand and senior management.
Securing Life Sciences Supply Chains
where Chemistry meets Biology,
where Products meet Services and
where Innovation meets Quality,
With an unrivalled research product portfolio of over
a million products and end-to-end manufacturing services,
we are science led and customer focused to solve problems,
taking pride in delivering products and projects that others cannot.
Our expertise and capability runs across
Complex Chemicals
Peptides and
Key Biologics
Biosynth is at The Edge of Innovation.
All from one trusted partner.
|
|
Biosynth Biologics Technology (Suzhou) Co., Ltd
Tel：0512-62605585
Mail：sales@biosynth.com
Add：Building C4 4th Floor, Lifebay Phase I,
No.999 Yinshanhu Road, Suzhou
Products
About Us
Mobile website
Follow us